Join
Live feed
·
INSIDERFilingvia Quantisnow
X4 Pharmaceuticals Inc. logo

Chief Commercial Officer Baldry Mark was granted 34,946 shares and sold $6,506 worth of shares (11,127 units at $0.58), increasing direct ownership by 96% to 48,509 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XFOR· X4 Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XFOR (X4 Pharmaceuticals Inc.) and more on Quantisnow.